Kennedy Jr. named eight new members to the U.S. Preventive Services Task Force, an influential panel of experts who assess ...

A psychedelic-like drug for a Parkinson's symptom, mice with half-human brains, and more biotech news in the Readout newsletter.

FDA's hiring bottleneck, Dems plan for health care oversight, and more from STAT's D.C. Diagnosis newsletter.

Cautious optimism in the Ebola outbreak, FDA still stymied by DOGE cuts, and other health updates from the Morning Rounds ...

Zocdoc enables appointment scheduling from chatbots and health plan websites, and more.

For all the talk of a hiring spree at the FDA after DOGE cuts last year, the reality is more complicated and filled with ...

Why a biotech hedge fund decided to build from the ground up a new company to develop a better, long-acting antibody ...

Sellas Life Sciences Group is a blowup waiting to happen. My prediction: Sellas’ experimental immunotherapy will fail to prolong survival compared to standard treatment for patients with acute myeloid ...

We’re very actively hiring,” Karim Mikhail, director of FDA’s Center for Biologics Evaluation and Research, told drug ...

Over the past 25 years, there’s been a dramatic change in how we understand children who don’t “listen,” writes behavioral ...

A breast cancer drug from AstraZeneca will now be available in England after a pricing deal was reached, in part a result of ...

The lawsuit seeks to halt the process of searching grant applications for specific terms to determine if they should be ...